Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

Total article views   Abstract views HTML views PDF downloads Totals
8,025 Dovepress* 5,956 897+ 916 6,853
PubMed Central* 0 1,172 334 1,172
Totals 5,956 2,069 1,250 8,025
*Since 12 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar